Becton Dickinson & Company

NYSE: BDX
$236.50
+$0.96 (+0.4%)
Closing Price on October 11, 2024

BDX Articles

Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
With the focus on health care expected to remain center stage for 2020, these Raymond James top health care stock picks all make sense now.
Monday's top analyst upgrades and downgrades included Amazon.com, Canopy Growth, CarMax, Chipotle Mexican Grill, Geron, Hess, Inogen, Occidental Petroleum, Snap, Teva Pharmaceutical, Vail Resorts and...
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
Co-Diagnostics has been the toast of Wall Street after it went from penny stock status to a revered coronavirus testing stock.
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up...
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Friday's top analyst upgrades, downgrades and initiations included Cardinal Health, Domino's, FedEx, Ford, General Electric, Grubhub, HSBC, Marvell Technology, Twitter and Uber.
These four health care stocks look like solid picks for the fourth quarter and into 2020. They are also favorite picks from Raymond James analysts.
These five Raymond James analyst favorite stock picks have substantial upside potential to the price targets and would make solid portfolio additions at current price levels.